Alnylam Pharmaceuticals, Inc. (ALNY)
465.34
-7.95
(-1.68%)
USD |
NASDAQ |
Dec 04, 16:00
465.37
+0.03
(+0.01%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price: 465.34 for Dec. 4, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 25.70 |
| Bristol Myers Squibb Co. | 51.95 |
| Vertex Pharmaceuticals, Inc. | 457.36 |
| Amgen, Inc. | 340.16 |
| BridgeBio Pharma, Inc. | 74.76 |
Price Related Metrics
| PE Ratio | 1934.89 |
| PS Ratio | 19.09 |
| Price to Book Value | 262.85 |
| Price to Free Cash Flow | 276.84 |
| Earnings Yield | 0.05% |
| Market Cap | 61.48B |
| Operating PE Ratio | 231.51 |
| Normalized PE Ratio | 300.20 |